JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilfeld, B. M.
Right arrow Articles by Vandenborne, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilfeld, B. M.
Right arrow Articles by Vandenborne, K.

Anesth Analg 2006;102:87-90
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000189562.86969.9f


AMBULATORY ANESTHESIA

Paul F. White

Total Knee Arthroplasty as an Overnight-Stay Procedure Using Continuous Femoral Nerve Blocks at Home: A Prospective Feasibility Study

Brian M. Ilfeld, MD, MS*, Peter F. Gearen, MD{dagger}, F. Kayser Enneking, MD*{dagger}, Linda F. Berry, RN{dagger}, Eugene H. Spadoni, PT{ddagger}, Steven Z. George, PhD, PT{ddagger}, and Krista Vandenborne, PhD, PT{ddagger}

*Departments of Anesthesiology, {dagger}Orthopaedics and Rehabilitation, and {ddagger}Physical Therapy, University of Florida, Gainesville, Florida

Address correspondence and reprint requests to Brian M. Ilfeld, MD, Department of Anesthesiology, P.O. Box 100254, 1600 SW Archer Road, Gainesville, FL 32610-0254. Address e-mail to bilfeld{at}ulf.edu.


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The average duration of hospitalization after total knee arthroplasty (TKA) in the United States is 4–5 days. In this two-phase study we investigated the feasibility of converting TKA into an overnight-stay procedure using a continuous femoral nerve block provided at home through postoperative day 4. Nine of 10 patients met discharge criteria and were discharged home the day after surgery. Pain was well controlled, opioid requirements and sleep disturbances were minimal, and patient satisfaction was high. Additional research is required to replicate these results in a controlled trial, define the appropriate subset of patients, and assess the incidence of complications associated with this practice before its mainstream use.


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
In the United States, criteria for home discharge after total knee arthroplasty (TKA) usually include the requirements that a) pain be controlled with only oral analgesics, and b) patients be able to ambulate at least 30 min so they may function at home (1). Consequently, the average duration of hospitalization after TKA in the United States is 4–5 days (2–5). A continuous femoral nerve block has been demonstrated to provide analgesia in hospitalized patients after TKA (6,7), but the possibility of shortening hospital duration while continuing to provide potent analgesia with ambulatory perineural infusion has not been investigated. Therefore, this study was designed to evaluate the feasibility of converting TKA into an overnight-stay procedure using a continuous femoral nerve block at home through postoperative day (POD) 4.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Hospitalized Phase
This phase was designed to evaluate and improve the proposed protocol while having patients remain in the controlled environment of the hospital for at least 3 nights. After University of Florida IRB approval, we enrolled ASA physical status I–II patients (18–80 yr) scheduled for primary, unilateral, tricompartmental, cemented TKA via a 12–18 cm midline skin incision and parapatellar approach secondary to osteoarthritis. Subjects were required to 1) live within 2 h of the hospital and 2) have a caretaker who would remain with them during perineural infusion. Exclusion criteria were contraindication to femoral nerve block, current chronic opioid therapy, allergy to study medications, known hepatic or renal insufficiency, and body mass index >40 kg/m2.

After obtaining written, informed patient consent, a femoral catheter (StimuCath, Arrow International, Reading, PA) was placed by one author (BMI) using a technique similar to one previously described (muscle contraction end-point: quadriceps at 0.20–0.40 mA) (8,9). Forty milliliters of mepivacaine, 1.5%, with epinephrine, 100 µg, was injected via the catheter. Patients were retained in the study if, within 15 min, they experienced a decreased sensation to cold temperature over the ipsilateral thigh and an inability to extend the knee. A perineural infusion of ropivacaine, 0.2%, was subsequently initiated (basal 8 mL/h, patient-controlled bolus-dose 4 mL, lockout time 30 min). For the surgical procedure, patients received a standardized general anesthetic with IV morphine titrated for a respiratory rate of 14.

Postoperatively, patients were transfused 2 U of packed red blood cells if their hematocrit decreased to less than 30 at any time, as is the standard of care after TKA for this surgeon (PFG). Patients received acetaminophen 975 mg every 6 h and enteric-coated aspirin 650 mg daily. Rescue opioid and route of administration were determined by pain severity: oral oxycodone 5 mg (numeric rating pain scale [NRS] <4), oral oxycodone 10 mg (NRS = 4–7), or IV morphine 2–4 mg (NRS>7). After 30 min, patients were reassessed and received oxycodone 5 mg (NRS<4) or IV morphine 2–4 mg (NRS>4).

On POD 2, a portable infusion pump (Pain Pump II, Stryker Corporation, Kalamazoo, MI) containing 400 mL of ropivacaine, 0.2%, was attached to the catheter (basal 5 mL/h, bolus 4 mL, lockout time 60 min) (10). The patient and caretaker were given pump and catheter instructions, physician telephone and pager numbers, and discharged home when all discharge criteria were met beginning on POD 3 (Table 1). Patients were contacted daily and patients’ caretakers removed the catheters on POD 4 (11).


View this table:
[in this window]
[in a new window]
 
Table 1. Prospectively Defined Discharge Criteria for Hospitalized and Ambulatory Phases

 
Ambulatory Phase
The purpose of the Ambulatory phase was to evaluate the feasibility of providing TKA as a single-night admission. Additional exclusion criteria were age >70 yr (12), any known cardiac disease, and any risk factors for deep vein thrombosis (13). Protocol changes were as follows: 1) after demonstration of correct catheter placement, 10 mL of ropivacaine, 0.5%, with epinephrine, 25 µg, was injected via the catheter; 2) intraoperatively, IV hetastarch 15 mL/kg was administered; 3) scheduled oxycontin (10 mg every 12 h) was added; 4) the portable infusion pump replaced the hospital-based pump 1 h before discharge; and 5) home discharge was allowed as early as POD 1.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Hospitalized Phase
Eight patients were enrolled (1 man and 7 women): mean (± sd) age = 63 (± 9) yr, height = 166 (± 8) cm, weight = 86 (± 9) kg. All but one patient had a femoral catheter placed successfully. In the one failure, the catheter was inserted per protocol with a dense motor block evolving within 2 min, but no sensory block could be identified and the patient was removed from the study (the postoperative infusion provided no apparent analgesia and the catheter was removed secondary to profound motor block). Of the 7 remaining patients, 5 (71%) met all discharge criteria on POD 1, and 2 (29%) on POD 2 (Fig. 1, Table 1, Table 2). All subjects underwent perineural infusion at home (Fig. 1, Table 2) until their catheters were removed on the afternoon of POD 4, with a median (10th–90th percentiles) infusion duration of 4 days and 8 (6–10) h.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1. Preoperative and postoperative average (Panel A) and worst (Panel B) pain for patients at rest with a femoral perineural ropivacaine, 0.2%, infusion after total knee arthroplasty. Pain was evaluated with a numeric rating pain scale (NRS, 0–10, 0 = no pain and 10 = worst imaginable pain). Data are expressed as median (horizontal bar) with 25th–75th (box) and 10th–90th (whiskers) percentiles. For tightly clustered data (e.g., Panel A, postoperative day 0, Hospitalized group), the median approximated the 75th and 90th percentile values. In this case, the median is 5.0 and only the 10th and 25th percentiles are clearly noted.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Postoperative Opioid Requirements, Dynamic Pain Scores, and Sleep Disturbances for Hospitalized and Ambulatory Phases

 

Ambulatory Phase
Ten patients were enrolled (6 men and 4 women) with the following characteristics: mean (± sd) age = 61 (± 5) yr, height = 172 (± 11) cm, weight = 95 (± 13) kg. All had a femoral catheter placed successfully. Nine patients (90%) met all of the discharge criteria on POD 1 (Fig. 1, Table 2) and were discharged home that day: 7 in the morning and 2 in the afternoon. One patient (10%) was discharged home in the morning of POD 4 because of a bowel obstruction that resolved POD 3. All subjects underwent perineural infusion at home (Fig. 1, Table 2) until their catheters were inadvertently dislodged (n = 2, morning of POD 4) or local anesthetic reservoir exhausted, resulting in a median (10th–90th percentiles) infusion duration of 4 days and 4 (0–10) h.


    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
This study demonstrates the feasibility of converting TKA into an overnight-stay procedure using an ambulatory continuous femoral nerve block as part of a multimodal analgesic regimen provided at home. Although this evidence demonstrates that TKA can be performed on an overnight-stay basis, it does not define the appropriate subset of patients and incidence of complications associated with this practice. Caution is warranted because after TKA, the median times to myocardial infarction and pulmonary embolism are 1 and 4 days, respectively (12). Further data are required to replicate these results in a controlled trial, define the appropriate subset of patients, and assess the incidence of complications associated with this practice before its mainstream use.

The authors gratefully acknowledge the invaluable assistance of the staff of both the Regional Anesthesia Induction Area ("Block Room") and General Clinical Research Center, including Doug Theriaque, MS, for figure compilation.


    Footnotes
 
Accepted for publication August 22, 2005.

Manufacturers donated the portable infusion pumps (Stryker Instruments, Kalamazoo, MI) and catheters (Arrow International, Reading, PA) used for this investigation. Stryker Instruments and Arrow International had no input into any aspect of study conceptualization, initiation, and design; data collection, analysis and interpretation; or manuscript preparation.

Supported, in part, by the University of Florida, Department of Anesthesiology, Arrow International, Stryker Instruments, National Institutes of Health grant K23-GM077026, and General Clinical Research Center Grant M01-RR00082. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of these entities.

Presented, in part, at the Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine, Toronto, Canada, April 22, 2005.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Enloe LJ, Shields RK, Smith K, et al. Total hip and knee replacement treatment programs: a report using consensus. J Orthop Sports Phys Ther 1996;23:3–11.[Web of Science][Medline]
  2. Munin MC, Kwoh CK, Glynn N, et al. Predicting discharge outcome after elective hip and knee arthroplasty. Am J Phys Med Rehabil 1995;74:294–301.[Web of Science][Medline]
  3. Mushinski M. Average charges for a total knee replacement: United States, 1994. Stat Bull Metrop Insur Co 1996;77:24–30.[Medline]
  4. Weinstein J. The Dartmouth atlas of musculoskeletal health care. Chicago, IL: AHA Press, 2000.
  5. American Academy of Orthopaedic Surgeons website. Available at: http://www.aaos.org.
  6. Singelyn FJ, Deyaert M, Joris D, et al. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg 1998;87:88–92.[Abstract/Free Full Text]
  7. Capdevila X, Barthelet Y, Biboulet P, et al. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology 1999;91:8–15.[Web of Science][Medline]
  8. Ilfeld BM, Enneking FK. Perineural catheter placement for a continuous nerve block: a single operator technique. Reg Anesth Pain Med 2003;28:154–5.[Medline]
  9. Ilfeld BM, Thannikary LJ, Morey TE, et al. Popliteal sciatic perineural local anesthetic infusion: a comparison of three dosing regimens for postoperative analgesia. Anesthesiology 2004;101:970–7.[Web of Science][Medline]
  10. Ilfeld BM, Morey TE, Enneking FK. Portable infusion pumps used for continuous regional analgesia: delivery rate accuracy and consistency. Reg Anesth Pain Med 2003;28:424–32.[Web of Science][Medline]
  11. Ilfeld BM, Enneking FK. Continuous peripheral nerve blocks at home: a review. Anesth Analg 2005;100:1822–33.[Abstract/Free Full Text]
  12. Mantilla CB, Horlocker TT, Schroeder DR, et al. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology 2002;96:1140–6.[Web of Science][Medline]
  13. Mantilla CB, Horlocker TT, Schroeder DR, et al. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology 2003;99:552–60.[Web of Science][Medline]



This article has been cited by other articles:


Home page
J Ultrasound MedHome page
E. R. Mariano, V. J. Loland, N. S. Sandhu, R. H. Bellars, M. L. Bishop, R. Afra, S. T. Ball, R. S. Meyer, R. C. Maldonado, and B. M. Ilfeld
Ultrasound Guidance Versus Electrical Stimulation for Femoral Perineural Catheter Insertion
J. Ultrasound Med., November 1, 2009; 28(11): 1453 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. M. Ilfeld, R. S. Meyer, L. T. Le, E. R. Mariano, B. A. Williams, K. Vandenborne, P. W. Duncan, D. I. Sessler, F. K. Enneking, J. J. Shuster, et al.
Health-Related Quality of Life After Tricompartment Knee Arthroplasty With and Without an Extended-Duration Continuous Femoral Nerve Block: A Prospective, 1-Year Follow-Up of a Randomized, Triple-Masked, Placebo-Controlled Study
Anesth. Analg., April 1, 2009; 108(4): 1320 - 1325.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
H.-N. Pang, N.-N. Lo, K.-Y. Yang, H.-C. Chong, and S.-J. Yeo
Peri-articular steroid injection improves the outcome after unicondylar knee replacement: A PROSPECTIVE, RANDOMISED CONTROLLED TRIAL WITH A TWO-YEAR FOLLOW-UP
J Bone Joint Surg Br, June 1, 2008; 90-B(6): 738 - 744.
[Abstract] [Full Text] [PDF]


Home page
Contin Educ Anaesth Crit Care PainHome page
C. R.K. Grant and M. R. Checketts
Analgesia for primary hip and knee arthroplasty: the role of regional anaesthesia
CEACCP, April 1, 2008; 8(2): 56 - 61.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. Zaric, K. Boysen, C. Christiansen, J. Christiansen, S. Stephensen, and B. Christensen
Combined Femoral-Sciatic Catheters for Postoperative Pain Treatment After Total Knee Replacement
Anesth. Analg., July 1, 2007; 105(1): 288 - 289.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. E. Chelly and B. Ben-David
Do Continuous Femoral Nerve Blocks Affect the Hospital Length of Stay and Functional Outcome?
Anesth. Analg., April 1, 2007; 104(4): 996 - 997.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
F. V. Salinas
Do Continuous Femoral Nerve Blocks Affect the Hospital Length of Stay and Functional Outcome?
Anesth. Analg., April 1, 2007; 104(4): 997 - 998.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Kehlet
Postoperative Analgesia and Hospital Stay: A Call for Better Study Design
Anesth. Analg., January 1, 2007; 104(1): 212 - 212.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
F. V. Salinas
Postoperative Analgesia and Hospital Stay: A Call for Better Study Design
Anesth. Analg., January 1, 2007; 104(1): 212 - 213.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilfeld, B. M.
Right arrow Articles by Vandenborne, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilfeld, B. M.
Right arrow Articles by Vandenborne, K.


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press